Celmatix Therapeutics is a preclinical-stage women’s health biotech focused on advancing groundbreaking therapeutics for women’s health. With its growing pipeline of innovative drug programs including an AMHR2 agonist program focused on ovarian aging, an oral FSH for infertility, and a JNK inhibitor program for endometriosis, Celmatix Therapeutics is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in women’s health. For more information, visit the company’s website at www.celmatix.com.
Company Details
- Employees
- 23
- Founded
- -
- Address
- 14 Wall Street, New York,ny 10005,united States
- Phone
- 1(646) 389-0245
- in****@****ix.com.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- celmatix.com
- Keywords
- Reproductive Biology and Medicine, Genomics, Bioinformatics, Biotech, Women's health, Drug Development.
- HQ
- New York, NY
Celmatix Therapeutics Questions
Celmatix Therapeutics's helpline number is 1(646) 389-0245
Celmatix Therapeutics's website is celmatix.com
Celmatix Therapeutics's LinkedIn profile is https://www.linkedin.com/company/celmatix
Celmatix Therapeutics has
23 employees.
View email and phone details for 23
employees at Celmatix Therapeutics.
Celmatix Therapeutics's industry is
Biotechnology Research
Celmatix Therapeutics's top competitors are
Conception,
Overture Life,
Evvy,
Kallyope,
Elektra Health,
Hera Biotech,
Oviva Therapeutics,
Aoa Dx,
Gameto,
Atossa Therapeutics, Inc..
Celmatix Therapeutics's support email address is info@celmatix.com.
Celmatix Therapeutics's categories are Biotechnology Research
Celmatix Therapeutics's founding year is 2009
